Physician
Neurology
Dr. Roger L. Albin, MD
|
|
Give Review
Dr. Roger L. Albin is an expert in the field of Neurology. He graduated from University of Pittsburgh School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Roger L. Albin, MD is also a published doctor. He has 88 paper published. The most recent paper is: Allelic Series of Huntington's Disease Knock-in Mice Reveals Expression Discorrelates. Roger Albin is registered with Medicare and accepts Medicare payments.
Publications
- Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
- Allelic Series of Huntington's Disease Knock-in Mice Reveals Expression Discorrelates.
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
- Out of one mutation, many Huntington's Disease effects.
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
- Modeling falls in Parkinson's Disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.
- Biallelic mutations in huntington Disease: A new case with just one affected parent, review of the literature and terminology.
- Targeting Metal-Aβ Aggregates with Bifunctional Radioligand [(11)C]L2-b and a Fluorine-18 Analogue [(18)F]FL2-b.
- Huntington Disease: pathogenesis and treatment.
- Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects.
- Factors associated with cognitive evaluations in the United States.
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study.
- Clinical markers for identifying cholinergic deficits in Parkinson's Disease.
- Differential effects of delayed aging on phenotype and striatal pathology in a murine model of huntington Disease.
- Nourish the roots while picking the fruit.
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson Disease.
- Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer Disease.
- Extra-nigral pathological conditions are common in Parkinson's Disease with freezing of gait: An in vivo positron emission tomography study.
- High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Prec...
- Magic shotgun for Parkinson's Disease?
- Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midBrain dopamine loss on striatal function.
- Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease.
- In Vivo Imaging of Human Cholinergic Nerve Terminals with (-)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses.
- Placebo: From belief to movement.
- Modifiable cardiovascular risk factors and axial motor impairments in Parkinson Disease.
- Modeling fall propensity in Parkinson's Disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic d...
- Gender differences in cholinergic and dopaminergic deficits in Parkinson Disease.
- (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson's Disease.
- Gait speed in Parkinson Disease correlates with cholinergic degeneration.
- The de-ubiquitinating enzyme ataxin-3 does not modulate Disease progression in a knock-in mouse model of Huntington Disease.
- Diabetes is associated with postural instability and gait difficulty in Parkinson Disease.
- C9ORF72 expansion in a family with bipolar disorder.
- Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging.
- Sources of Technical Variability in Quantitative LC-MS Proteomics: Human Brain Tissue Sample Analysis.
- Dopaminergic treatment and nonmotor features of Parkinson Disease: The horse lives.
- β-amyloid and postural instability and gait difficulty in Parkinson's Disease at risk for dementia.
- Aβ-amyloid deposition in patients with Parkinson Disease at risk for development of dementia.
- Heterogeneity of cholinergic denervation in Parkinson's Disease without dementia.
- Na(+) and K(+) ion imbalances in Alzheimer's Disease.
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson Disease.
- Guidelines for the use and interpretation of assays for monitoring autophagy.
- Genome-wide DNA methylation differences between late-onset Alzheimer's Disease and cognitively normal controls in human frontal cortex.
- Do neurologists make a difference in Parkinson Disease care?
- Treating Mouse Models of Huntington Disease.
- Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's Disease.
- Cerebral glucose metabolic features of Parkinson Disease and incident dementia: longitudinal study.
- Early alterations of autophagy in Huntington Disease-like mice.
- Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington Disease.
- Risk of sleep-disordered breathing in Parkinson's Disease.
- Comparing fludeoxyglucose F18-PET assessment of regional Cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cogniti...
- Cholinergic denervation occurs early in Parkinson Disease.
- What sort of change to believe in: an alternate opinion.
- In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington Disease.
- Rodent genetic models of Huntington Disease.
- Dopamine and Epilepsy: hints of complex subcortical roles.
- The case of the colorless crystals.
- Spared caudal brainstem SERT binding in early Parkinson's Disease.
- Mortalin: a protein associated with progression of Parkinson Disease?
- Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.
- Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer.
- Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's Disease.
- Parkinson's Disease: background, diagnosis, and initial management.
- Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson Disease.
- Practice Parameters for Parkinson Disease: signposts for clinical research.
- Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function.
- Abnormalities of germ Cell maturation and sertoli Cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein.
- Report from the neurology scientific integrity advisor: year 1.
- A new hypothesis for Dystonia.
- 11C-DTBZ and 18F-FDG PET measures in differentiating Dementias.
- Genetics of subthalamic nucleus in development and Disease.
- Embryonic stem Cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression.
- Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman Ataxia and Ataxia/dystonia in the jittery mouse.
- mGluRs: a target for pharmacotherapy in Parkinson Disease.
- Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochon...
- Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
- Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar Degeneration, intestinal and hepatic steatosis, and hypoglycemia.
- The mind's eye, looking inward? In search of executive control in internal attention shifting.
- Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical Dystonia.
- Initial agonist treatment of Parkinson Disease: a critique.
- Striatal monoaminergic terminals in Lewy body and Alzheimer's Dementias.
- Cholinergic vesicular transporters in progressive supranuclear Palsy.
- The unfolded protein response is activated in Disease-affected brain regions in progressive supranuclear palsy and Alzheimer's Disease.
- Mouse models of neurodevelopmental Disease of the Basal Ganglia and associated circuits.
- Insomnia and sleepiness in Parkinson Disease: associations with symptoms and comorbidities.
- Modeling test and treatment strategies for presymptomatic Alzheimer Disease.
Schools
University of Pittsburgh Main Campus
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Pittsburgh School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1568551422 | |
| NPPES Provider LastName | ALBIN | |
| NPPES Provider FirstName | ROGER | |
| NPPES Provider ZIPCode | 481092700 | |
| NPPES Provider State | MI | |
| Specialty Description | Neurology | |
| Total Claim Count | 606.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568551422 |
| Last Name Of The Provider | ALBIN |
| First Name Of The Provider | ROGER |
| View All |
Similar Doctors
|
|
Dr. William T. Dauer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikram G. Shakkottai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kinshuk Sahaya, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bradley J. Davis, MD |
|
|
Dr. Kerry L. Hulsing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole D. Reams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert R. Coleman, MD |
|
|
Dr. Henry L. Paulson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jonathan D. Snider, MD
This Doctor is OpenDoctor Recommended.
|